Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Theravance Biopharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 107 | 109 | +2 |
| Shares | 53.5M | 60.8M | +7.24M (+13.5%) |
| Value | $1.09B | $883.1M | −$209.6M (−19.2%) |
New holders (20)
Institutions that held Theravance Biopharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Maven Securities LTD | 1,342,574 | $20.1M | 2.12% |
| Highbridge Capital Management LLC | 587,666 | $8.53M | 0.26% |
| Candriam Luxembourg S.C.A. | 475,696 | $6.91M | 0.05% |
| Woodline Partners LP | 374,912 | $5.44M | 0.10% |
| Altium Capital Management LP | 220,000 | $3.19M | 0.74% |
| Monashee Investment Management LLC | 200,000 | $2.90M | 0.35% |
| Farallon Capital Management, L.L.C. | 96,000 | $1.39M | 0.01% |
| ExodusPoint Capital Management, LP | 90,864 | $1.32M | 0.02% |
| Caas Capital Management LP | 61,450 | $892.0K | 0.05% |
| Hound Partners, LLC | 49,830 | $724.0K | 0.04% |
| Pura Vida Investments, LLC | 48,766 | $708.0K | 0.05% |
| Walleye Capital LLC | 16,688 | $242.0K | 0.01% |
| Bridgefront Capital, LLC | 15,714 | $228.0K | 0.09% |
| XTX Topco Ltd | 14,269 | $207.0K | 0.07% |
| Handelsbanken Fonder AB | 13,516 | $196.0K | 0.00% |
| SG Americas Securities, LLC | 8,042 | $117.0K | 0.00% |
| Newbridge Financial Services Group, Inc. | 2,000 | $29.0K | 0.02% |
| Exos Asset Management LLC | 1,796 | $26.0K | 0.01% |
| Simplex Trading, LLC | 750 | $10.0K | 0.00% |
| Quadrant Capital Group LLC | 25 | $0 | 0.00% |
Sold out (18)
Institutions that held Theravance Biopharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| California Public Employees Retirement System | 93,700 | $1.91M |
| D. E. Shaw & Co., Inc. | 56,014 | $1.14M |
| Two Sigma Investments, LP | 40,962 | $836.0K |
| First Trust Advisors LP | 30,564 | $624.0K |
| Two Sigma Advisers, LP | 29,800 | $608.0K |
| Tocqueville Asset Management L.P. | 27,500 | $561.0K |
| Old West Investment Management, LLC | 17,592 | $359.0K |
| Ergoteles LLC | 14,500 | $296.0K |
| Jane Street Group, LLC | 14,192 | $290.0K |
| SG3 Management, LLC | 13,000 | $265.0K |
| Jefferies Group LLC | 12,414 | $253.4K |
| HSBC Holdings PLC | 10,412 | $210.0K |
| Nisa Investment Advisors, LLC | 3,800 | $78.0K |
| Bank of Montreal | 1,603 | $35.0K |
| Cutler Group LP | 1,500 | $30.0K |
| Jacobi Capital Management LLC | 250 | $5.00K |
| Versant Capital Management, Inc | 239 | $5.00K |
| TCI Wealth Advisors, Inc. | 92 | $2.00K |